Role of horizontal transfer of the transposon Tn1546 in the nosocomial spread of vanA vancomycin-resistant enterococci at a tertiary care hospital in Korea

Infection Control and Hospital Epidemiology

Volumn 27, Issue 10, 2006, Pages 1081-1087

  Yoo, Soo Jin ^a,b   Sung, Heungsup ^a   Cho, Young Uk ^a   Kim, Mi Na ^a,c   Pai, Chik Hyun ^a   Kim, Yang Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA FINGERPRINTING; DNA POLYMORPHISM; GENE TRANSFER; GENOTYPE; HOSPITAL INFECTION; KOREA; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT; TERTIARY HEALTH CARE; TRANSPOSON; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CROSS INFECTION; DNA FINGERPRINTING; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; GENE TRANSFER, HORIZONTAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KOREA; POLYMERASE CHAIN REACTION; VANCOMYCIN RESISTANCE; VARIATION (GENETICS);

EID: 33750548240     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/507279     Document Type: Article

References (40)

1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319:157-161.
2. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1:57-58.
3. Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1:314-325.
4. Martone WJ. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998; 19:539-545.
5. Goossens H. Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Infect Control Hosp Epidemiol 1998; 19:546-551.
6. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348:1615-1619.
7. Pai CH, Kim MN. Antimicrobial resistance in enterococci. Yonsei Med J 1998; 39:554-561.
8. Kim SJ, Lee NY, Song JH, et al. A study on molecular epidemiology of vancomycin-resistant enterococci isolated from hospitals in Korea. Korean J Infect Dis 1998; 30:1-9.
9. Oh HS, Kim EC, Oh MD, Choe KW. Outbreak of vancomycin resistant enterococcus in a hematology/oncology unit in a Korean University Hospital, and risk factors related to patients, staff, hospital care and facilities. Scand J Infect Dis 2004; 36:790-794.
10. Lee KW, Kim MY, Kang SH, et al. Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli. Yonsei Med J 2003; 44:571-578.
11. Yoon SW, Kim OS, Peck KR, et al. Efficacy of infection control strategies for vancomycin-resistant enterococci in a tertiary care hospital. Korean J Infect Dis 2002; 34:81-88.
12. Shin DH, Park JH, Shin JH, Suh SP, Ryang DW, Kim SJ. A molecular epidemiologic study on vancomycin-resistant enterococci isolated from clinical specimens over a 5-year Period. Korean J Infect Dis 2000; 32:203-211.
13. Lee WG, Jernigan JA, Rasheed JK, Anderson GJ, Tenover FC. Possible horizontal transfer of the vanB2 gene among genetically diverse strains of vancomycin-resistant Enterococcus faecium in a Korean hospital. J Clin Microbiol 2001; 39:1165-1168.
14. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995; 123:250-259.
15. Kawalec M, Gniadkowski M, Hryniewicz W. Outbreak of vancomycin-resistant enterococci in a hospital in Gdask, Poland, due to horizontal transfer of different Tn1546-like transposon variants and clonal spread of several strains. J Clin Microbiol 2000; 38:3317-3322.
16. Simonsen GS, Haaheim H, Dahl KH, et al. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. Microb Drug Resist 1998; 4:313-318.
17. Song JY, Hwang IS, Eom JS, et al. Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J Intern Med 2005; 20:55-62.
18. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically. 5th ed. Approved standard M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
19. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993; 37:2311-2317.
20. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175:117-127.
21. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
22. Erratum in: Am J Infect Control 1988; 16:177.
23. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990; 28:2059-2063.
24. Erratum in: J Clin Microbiol 1991; 29:418.
25. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
26. Haaheim H, Dahl KH, Simonsen GS, Olsvik O, Sundsfjord A. Long PCRs of transposons in the structural analysis of genes encoding acquired glycopeptide resistance in enterococci. Biotechniques 1998; 24:432-437.
27. Palepou MF, Adebiyi AM, Tremlett CH, Jensen LB, Woodford N. Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. J Antimicrob Chemother 1998; 42:605-612.
28. Descheemaeker P, Ieven M, Chapelle S, et al. Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J Infect Dis 2000; 181:235-241.
29. Schouten MA, Willems RJ, Kraak WA, Top J, Hoogkamp-Korstanje JA, Voss A. Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother 2001; 45:986-989.
30. Scagnelli M, Pellizer G, de Lalla F, et al. Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in Northern Italy. Eur J Clin Microbiol Infect Dis 2001; 20:609-616.
31. Kim WJ, Weinstein RA, Hayden MK. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 1999; 179:163-171.
32. Bonten MJ, Slaughter S, Hayden MK, Nathan C, van Voorhis J, Weinstein RA. External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med 1998; 26:2001-2004.
33. de Lencastre H, Brown AE, Chung M, Armstrong D, Tomasz A. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital. Microb Drug Resist 1999; 5:113-129.
34. Yu HS, Seol SY, Cho DT. Diversity of Tn1546-like elements in vancomycin-resistant enterococci isolated from humans and poultry in Korea. J Clin Microbiol 2003; 41:2641-2643.
35. Huh JY, Lee WG, Lee K, Shin WS, Yoo JH. Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. J Clin Microbiol 2004; 42:1897-1902.
36. Bates J, Jordens Z, Selkon JB. Evidence for an animal origin of vancomycin-resistant enterococci. Lancet 1993; 342:490-491.
37. Torres C, Tenorio C, Portillo A, et al. Intestinal colonization by vanA- or vanB2-containing enterococcal isolates of healthy animals in Spain. Microb Drug Resist 2003; 9(Suppl 1):S47-S52.
38. Willems RJ, Top J, van den Braak N, et al. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 1999; 43:483-491.
39. Willems RJ, Top J, van Santen M, et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11:821-828.
40. Darini AL, Palepou MF, Woodford N. Effects of the movement of insertion sequences on the structure of VanA glycopeptide resistance elements in Enterococcus faecium. Antimicrob Agents Chemother 2000; 44:1362-1364.